Terms: = Kidney tumors AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II
24 results:
1. In vivo safety and biodistribution profile of Klotho-enhanced human urine-derived stem cells for clinical application.
Kim SH; Lee SH; Jin JA; So HJ; Lee JU; Ji MJ; Kwon EJ; Han PS; Lee HK; Kang TW
Stem Cell Res Ther; 2023 Dec; 14(1):355. PubMed ID: 38072946
[TBL] [Abstract] [Full Text] [Related]
2. A clinically relevant large-scale biomanufacturing workflow to produce natural killer cells and natural killer cell-derived extracellular vesicles for cancer immunotherapy.
St-Denis-Bissonnette F; Cummings SE; Qiu S; Stalker A; Muradia G; Mehic J; Mediratta K; Kaczmarek S; Burger D; Lee SH; Wang L; Lavoie JR
J Extracell Vesicles; 2023 Dec; 12(12):e12387. PubMed ID: 38054534
[TBL] [Abstract] [Full Text] [Related]
3. SETD2 Loss and ATR Inhibition Synergize to Promote cGAS Signaling and Immunotherapy Response in Renal Cell Carcinoma.
Liu XD; Zhang YT; McGrail DJ; Zhang X; Lam T; Hoang A; Hasanov E; Manyam G; Peterson CB; Zhu H; Kumar SV; Akbani R; Pilie PG; Tannir NM; Peng G; Jonasch E
Clin Cancer Res; 2023 Oct; 29(19):4002-4015. PubMed ID: 37527013
[TBL] [Abstract] [Full Text] [Related]
4. Identification of Cytosolic DNA Sensor cGAS-STING as Immune-Related Risk Factor in Renal Carcinoma following Pan-Cancer Analysis.
Wu Z; Lin Y; Liu LM; Hou YL; Qin WT; Zhang L; Jiang SH; Yang Q; Bai YR
J Immunol Res; 2022; 2022():7978042. PubMed ID: 35983076
[TBL] [Abstract] [Full Text] [Related]
5. PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer.
Chabanon RM; Morel D; Eychenne T; Colmet-Daage L; Bajrami I; Dorvault N; Garrido M; Meisenberg C; Lamb A; Ngo C; Hopkins SR; Roumeliotis TI; Jouny S; Hénon C; Kawai-Kawachi A; Astier C; Konde A; Del Nery E; Massard C; Pettitt SJ; Margueron R; Choudhary JS; Almouzni G; Soria JC; Deutsch E; Downs JA; Lord CJ; Postel-Vinay S
Cancer Res; 2021 Jun; 81(11):2888-2902. PubMed ID: 33888468
[TBL] [Abstract] [Full Text] [Related]
6.
Vallejo-Armenta P; Santos-Cuevas C; Soto-Andonaegui J; Villanueva-Pérez RM; González-Díaz JI; García-Pérez FO; Arrellano-Zarate A; Luna-Gutiérrez M; Azorín-Vega E; Ocampo-García B; Ferro-Flores G
Contrast Media Mol Imaging; 2020; 2020():2525037. PubMed ID: 32410920
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma.
Msaouel P; Malouf GG; Su X; Yao H; Tripathi DN; Soeung M; Gao J; Rao P; Coarfa C; Creighton CJ; Bertocchio JP; Kunnimalaiyaan S; Multani AS; Blando J; He R; Shapiro DD; Perelli L; Srinivasan S; Carbone F; Pilié PG; Karki M; Seervai RNH; Vokshi BH; Lopez-Terrada D; Cheng EH; Tang X; Lu W; Wistuba II; Thompson TC; Davidson I; Giuliani V; Schlacher K; Carugo A; Heffernan TP; Sharma P; Karam JA; Wood CG; Walker CL; Genovese G; Tannir NM
Cancer Cell; 2020 May; 37(5):720-734.e13. PubMed ID: 32359397
[TBL] [Abstract] [Full Text] [Related]
8. Dynamic compartmentalization of purine nucleotide metabolic enzymes at leading edge in highly motile renal cell carcinoma.
Wolfe K; Kofuji S; Yoshino H; Sasaki M; Okumura K; Sasaki AT
Biochem Biophys Res Commun; 2019 Aug; 516(1):50-56. PubMed ID: 31196624
[TBL] [Abstract] [Full Text] [Related]
9. New Pt-NNSO core anticancer agents: Structural optimization and investigation of their anticancer activity.
Chong SX; Jin Y; Au-Yeung SC; To KK
J Inorg Biochem; 2017 May; 170():34-45. PubMed ID: 28214754
[TBL] [Abstract] [Full Text] [Related]
10. AMPK and Endothelial Nitric Oxide Synthase Signaling Regulates K-Ras Plasma Membrane Interactions via Cyclic gmp-Dependent Protein Kinase 2.
Cho KJ; Casteel DE; Prakash P; Tan L; van der Hoeven D; Salim AA; Kim C; Capon RJ; Lacey E; Cunha SR; Gorfe AA; Hancock JF
Mol Cell Biol; 2016 Dec; 36(24):3086-3099. PubMed ID: 27697864
[TBL] [Abstract] [Full Text] [Related]
11. Essential role of the cgmp/PKG signaling pathway in regulating the proliferation and survival of human renal carcinoma cells.
Ren Y; Zheng J; Yao X; Weng G; Wu L
Int J Mol Med; 2014 Nov; 34(5):1430-8. PubMed ID: 25244411
[TBL] [Abstract] [Full Text] [Related]
12. Rebmab200, a humanized monoclonal antibody targeting the sodium phosphate transporter NaPi2b displays strong immune mediated cytotoxicity against cancer: a novel reagent for targeted antibody therapy of cancer.
Lopes dos Santos M; Yeda FP; Tsuruta LR; Horta BB; Pimenta AA; Degaki TL; Soares IC; Tuma MC; Okamoto OK; Alves VA; Old LJ; Ritter G; Moro AM
PLoS One; 2013; 8(7):e70332. PubMed ID: 23936189
[TBL] [Abstract] [Full Text] [Related]
13. Retronectin-assisted retroviral transduction of primary human T lymphocytes under good manufacturing practice conditions: tissue culture bag critically determines cell yield.
Lamers CH; van Elzakker P; van Steenbergen SC; Sleijfer S; Debets R; Gratama JW
Cytotherapy; 2008; 10(4):406-16. PubMed ID: 18574773
[TBL] [Abstract] [Full Text] [Related]
14. [11C]Vinblastine syntheses and preliminary imaging in cancer patients.
Solbach C; Patt M; Reimold M; Blocher A; Dohmen BM; Bares R; Zeller KP; Machulla HJ
J Pharm Pharm Sci; 2007; 10(2):266s-276s. PubMed ID: 17718930
[TBL] [Abstract] [Full Text] [Related]
15. Process validation and clinical evaluation of a protocol to generate gene-modified T lymphocytes for imunogene therapy for metastatic renal cell carcinoma: gmp-controlled transduction and expansion of patient's T lymphocytes using a carboxy anhydrase IX-specific scFv transgene.
Lamers CH; van Elzakker P; Langeveld SC; Sleijfer S; Gratama JW
Cytotherapy; 2006; 8(6):542-53. PubMed ID: 17148030
[TBL] [Abstract] [Full Text] [Related]
16. Induction of apoptosis in renal cell carcinoma by reactive oxygen species: involvement of extracellular signal-regulated kinase 1/2, p38delta/gamma, cyclooxygenase-2 down-regulation, and translocation of apoptosis-inducing factor.
Ambrose M; Ryan A; O'Sullivan GC; Dunne C; Barry OP
Mol Pharmacol; 2006 Jun; 69(6):1879-90. PubMed ID: 16543392
[TBL] [Abstract] [Full Text] [Related]
17. 3',5'-Cyclic diguanylic acid (c-di-gmp) inhibits basal and growth factor-stimulated human colon cancer cell proliferation.
Karaolis DK; Cheng K; Lipsky M; Elnabawi A; Catalano J; Hyodo M; Hayakawa Y; Raufman JP
Biochem Biophys Res Commun; 2005 Apr; 329(1):40-5. PubMed ID: 15721270
[TBL] [Abstract] [Full Text] [Related]
18. Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.
Babatz J; Röllig C; Oelschlägel U; Zhao S; Ehninger G; Schmitz M; Bornhäuser M
J Hematother Stem Cell Res; 2003 Oct; 12(5):515-23. PubMed ID: 14594508
[TBL] [Abstract] [Full Text] [Related]
19. [Specific cellular immunotherapy of renal cell carcinoma. Current status and prospects].
Ringhoffer M; Gschwend JE
Urologe A; 2002 May; 41(3):249-57. PubMed ID: 12132274
[TBL] [Abstract] [Full Text] [Related]
20. Guanylin regulatory peptides: structures, biological activities mediated by cyclic gmp and pathobiology.
Forte LR
Regul Pept; 1999 May; 81(1-3):25-39. PubMed ID: 10395405
[TBL] [Abstract] [Full Text] [Related]
[Next]